urine screening for metabolic disorders

55
Urine Screening for Metabolic Disorders Ang. Avena. Blas. Tagarao. 3FMT

Upload: glormina-asprec-avena

Post on 10-Dec-2015

109 views

Category:

Documents


11 download

DESCRIPTION

urine screening for metabolic disorders

TRANSCRIPT

Page 1: Urine Screening for Metabolic Disorders

Urine Screening for Metabolic DisordersAng. Avena. Blas. Tagarao. 3FMT

Page 2: Urine Screening for Metabolic Disorders

Metabolic Substances in the

Urine Overflow Type

- disruption of normal metabolic pathway

- increase in plasma concentrations from the non-metabolized substances.

Renal Type

- abnormal accumulations of substances that are caused by malfunctions in the mechanism of tubular reabsorption

Page 3: Urine Screening for Metabolic Disorders

Amino Acid Disorders

• Phenylalanine-Tryptophan Disorders• Branched Chain Amino Acid Disorders• Cysteine and Homocysteine Disorders• Porphyrin Disorders• Mucopolysaccharide Disorders• Purine Disorders• Carbohydrate Disorders

Page 4: Urine Screening for Metabolic Disorders

Phenylalanine-Tryptophan Disorders

• Phenylketonuria • Tyroslyuria• Melanuria• Alkaptonuria

Page 5: Urine Screening for Metabolic Disorders

Phenylketonuria (PKU)

Inherited autosomal recessive trait

absence of activity of the enzyme phenylalanine hydroxylase (PAH)

catalyzes the conversion of phenylalanine to tyrosine

Catabolites: phenylpyruvic acid, phenyllactic acid, phenylacetic acid, phenylacetylglutamine

Types: Mild PKU (600-1200 μmol/L) Non-PKU mild hyperphenylalaninenemia (180-600 μmol/L; no

phenylketones)

Page 6: Urine Screening for Metabolic Disorders

Can cause:Mental retardationsConvulsionsBehavior problems Skin rashMusty body odor

Urine: Musty Odor

Test: Ferric Chloride Tube Test

Procedure: 5 drops 10% FeCl3 + 1mL urine sample

FeCl3 reacts w/ phenylpyruvic acid = Permanent blue-green color.

Page 7: Urine Screening for Metabolic Disorders
Page 8: Urine Screening for Metabolic Disorders
Page 9: Urine Screening for Metabolic Disorders

Tyrosyluria

accumulation of excess tyrosine in the plasma (tyrosinemia)

either inherited or metabolic defect

Urine: excess tyrosine or , p-hydroxyphenylpyruvic acid and p-hydroxy phenyllatic acid.

Page 10: Urine Screening for Metabolic Disorders

Three types of Tyrosinemia:

1) Type I – low levels of the enzyme fumarylacetoacetate hydrolase, the last of five enzymes needed to break down tyrosine

2) Type II –a deficiency of the enzyme tyrosine aminotransferase, the first in a series of five enzymes that converts tyrosine to smaller molecules

3) Type III – deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase, ncluded in the five enzymes needed to break down tyrosine

Page 11: Urine Screening for Metabolic Disorders

Test: Nitroso-Napthol Test

Procudure:

1mL of 2.63N nitric acid + 1 drop of 21.5% sodium nitrite + 0.1mL 1-nitroso-2-napthol + 5 drops of urine

Mix and wait for 5 minutes

Result: Orange-red color which indicates tyrosine metabolites

Page 12: Urine Screening for Metabolic Disorders

Melanuria Darkening of the urine = increase of melanin in

the body

Melanin - is the pigment responsible for the dark color of hair, skin and eyes.

Serious finding: if urinary melanin is elevated - indicates proliferation of the normal melanin-producing cells (melanocytes)

Urine: Dark urine

5,6-dihydoxyindole - a colorless precursor of melanin

secreted by Malignant melanoma oxidizes to melanogen melanin

Page 13: Urine Screening for Metabolic Disorders

Alkaptonuria Inborn metabolic disease transmitted as an autosomal

recessive gene

HDG gene - the lack of the enzyme homogentisate oxidase (needed in the metabolism of tyrosine and phenylalanine)

Test: Homogentisic Acid Test

Procedure:

0.5 mL of urine + 4 mL of 3% silver nitrite and mix

Result: Black color after 24 hours

Other tests

Ferric Chloride Test: transient deep blue color

Clinitest: Yellow precipitate

Page 14: Urine Screening for Metabolic Disorders

Branched Chain Amino Acid Disorders

• Maple Syrup Urine Disorders• Organic Acidemia • Indicanuria• 5-Hydoxyindolacetic Acid

Page 15: Urine Screening for Metabolic Disorders

Maple Syrup Urine Disorders (MSUD)

rare autosomal recessive genetic inherited disorder

absence or reduced activity of the enzyme branched-chain-α-ketoacid decarboxylase

blocking the normal metabolism of the three essential branched-chain amino acids leucine, isoleucine and valine.

Page 16: Urine Screening for Metabolic Disorders

1:150,000 births

Urine: Maple syrup or burnt sugar odor

Test: 2,4-Dinitrophenylhydrazine (DNPH) Test

Procedure

10 drops of 0,2% 2,4-DNPH + 2N HCL +1 mL urine

Wait for 10 minutes

Result: Yellow turbidity and precipitate.

Page 17: Urine Screening for Metabolic Disorders
Page 18: Urine Screening for Metabolic Disorders

Organic Acidemia

Three most frequently encountered disorders:

Isovaleric

Propionic

Methylmalonic

The presence of these three can be detected by newborn screening programs using MS/MS.

Page 19: Urine Screening for Metabolic Disorders

Isovaleric academia autosomal recessive metabolic disorder from a

deficiency of the enzyme isovaleryl-CoA dehydrogenase

preventing normal metabolism of the amino acid leucine.

1:250,000 births

Urine: Sweaty feet odor urine

Page 20: Urine Screening for Metabolic Disorders
Page 21: Urine Screening for Metabolic Disorders

Propionic and Methylmalonic Acidemia

due from the errors in the metabolic pathway converting isoleucine, valine and threonine and methionine to succinyl CoA.

Page 22: Urine Screening for Metabolic Disorders
Page 23: Urine Screening for Metabolic Disorders
Page 24: Urine Screening for Metabolic Disorders

Indicanuria Due to certain intestinal disorders, presence of

abnormal bacteria, malabsorption syndrome

Hartnup disease - increase amounts of tryptophan are converted to indole

Excess indole is then reabsorbed from the intestine into the bloodstream and circulated to the liver, converted to indican and then excreted in the urine.

Urine: Colorless

Urine exposed to air: oxidized to Indigo Blue.

Page 25: Urine Screening for Metabolic Disorders

5-Hydoxyindolacetic Acid (5-HIAA)

The degradation product of serotonin that is excreted in the urine normally in small amounts.

Serotonin - produced from the second metabolic pathway of tryptophan by the argentaffin cells in the intestine.

If there are carcinoid tumors involving the argentaffin cells develop = increase in the production of serotonin results in the elevation of urinary 5-HIAA levels.

Page 26: Urine Screening for Metabolic Disorders

Cysteine and Homocysteine

Disorders

• Cystinuria• Cystinosis• Homocystinuria

Page 27: Urine Screening for Metabolic Disorders

Cystinuria

inherited renal tubular disorder.

Two forms:

1. patients cannot reabsorb lysine, ornithine, arginine, or cysteine

2. only cysteine and lysine cannot be reabsorbed.

more likely to have pathological urinary cysteine crystals and stones composed of cysteine.

Cystine forms urinary calculi (insoluble, unless alkalinize)

Page 28: Urine Screening for Metabolic Disorders

Test: Cyanide nitroprusside test

Result: Red Purple Color

Treatment: More water intake (4L/day)PenicillinasePercutaneous nephrolithotripsy

Page 29: Urine Screening for Metabolic Disorders

Cystinosis

Inborn Errors of Metabolism (IEM) – can range from from severe and fatal in infancy to a milder adult form.

defect in the lysosomal membrane

prevents release of cystine into the cellular cytoplasm for metabolism

Leads to: Deposition of cysteine crystals in many cells of the body.

Page 30: Urine Screening for Metabolic Disorders

 Patients w/Fanconi syndrome deposits of cysteine in the cells of the proximal convoluted tubule interfere with reabsorption and of these crystal deposits in cells can lead to early renal failure.

Mild Form: No kidney involvement

polyuria and positive urine tests for reducing substances

Urinalysis tests = lack of ability to vary specific gravity.

Test: cyanide nitroprusside test

Result: Positive  

  

Page 31: Urine Screening for Metabolic Disorders
Page 32: Urine Screening for Metabolic Disorders

Homocystinuria Lack of the enzyme cystathionine β-synthase

necessary for the metabolism of the amino acid methionine

increased plasma and urine levels of methionine and of the precursor homocysteine.

Result to: failure to thrive mental retardation Cataractsincreased thrombosis riskDeath

Page 33: Urine Screening for Metabolic Disorders

Prevention: Diet modification with reduction in methionine

sourceshigh doses of Vitamin B6

Test: Cyanide nitroprusside test

Result: Positive

Other test:Silver Nitroprusside test – needed to differentiate

from the cystine disorders.

Homocystinuria = postive

Cystinuria = negative

Cystinosis = negative

Page 34: Urine Screening for Metabolic Disorders
Page 35: Urine Screening for Metabolic Disorders

Porphyrin Disorders

• Porphyrins – complex iron-fee cyclic substances; intermediates in the biosynthetic pathway of heme.

• Porphyrins differ in the side chains present at the eight available positions on the pyrrole rings.

• Major sites for Porphyrin production are:1. bone marrow - intermediates in the synthesis of

hemoglobin2. liver and other tissues - produce intermediates for

other heme proteins like myoglobin.

Page 36: Urine Screening for Metabolic Disorders

Porphyrins can be seen elevated in: urine, feces, and/or blood

Porphobilinogen (PBG) and the porphyrinogens -colorless, non-fluorescent substances

Oxidized forms or the Porphyrins have red pigments under the microscope

Urine: port wine / burgundy color

Common method for separating individual porphyrin: high performance liquid chromatography

Page 37: Urine Screening for Metabolic Disorders

Delta-aminolevulenic Acid Dehydrogenase Deficiency Porphyria Delta-aminolevulinic acid dehydratase (ALAD),

also known as porphobilinogen synthase, catalyzes the second step of heme synthesis. Deficiency of this enzyme produces ALAD deficiency porphyria (ADP), an extremely rare cause of acute porphyria.

a rare form of acute porphyria

aminolevulenic acid is increased

PBG is not increased

Page 38: Urine Screening for Metabolic Disorders

Acute porphyriasrapid testing is important.

Porphobilinogen is increased patients with symptoms of acute porphyrias

PBG testing is both sensitive and specific

Measurement of PBG is often combined with measurments for delta aminolevulenic acid and total urine porphyrins.

Page 39: Urine Screening for Metabolic Disorders

Cutaneous Porphyria

measuring total plasma Porphyrins is effective for screening patients with skin photosensitivity

Plasma Porphyrins are rarely increased in other medical conditions.

Page 40: Urine Screening for Metabolic Disorders

Mucopolysaccharide Disorders

• Mucopolysaccharidoses Hurler Syndrome Hunter Syndrome Sanfilippo Syndrome

Page 41: Urine Screening for Metabolic Disorders

Mucopolysaccharidesaka Glycosaminoglycans

group of large compounds located primarily in connective tissue (CT)

consists of a protein core with numerous polysaccharide branches

products most frequently found in urine are dermatan sulfate, keratan sulfate, and heparan sulfate

Page 42: Urine Screening for Metabolic Disorders

Mucopolysaccharidoses

inherited disorders in the metabolism of mucopolysaccharides

preventing complete breakdown of polysaccharide portion

accumulation of incompletely metabolized polysaccharide portion in lysosomes of CT cells

increased excretion in urine

Page 43: Urine Screening for Metabolic Disorders

Types

1. Hurler Syndrome

abnormal skeletal structure

severe mental retardation

mucopolysaccharides accumulate in the cornea of the eye 

2. Hunter Syndrome

abnormal skeletal structure

severe mental retardation

sex-linked recessive (rarely seen in females)

3. Sanfilippo Syndrome

mental retardation

 

Page 44: Urine Screening for Metabolic Disorders

Diagnosis: Urinary screening test – newborn

1. acid-albumin and CTAB turbidity test

2. metachromatic staining spot test

Result: white turbidity (+)

Page 45: Urine Screening for Metabolic Disorders

Purine Disorders• Lesch-Nyhan Disease

Carbohydrate Disorders

• Melituria

Page 46: Urine Screening for Metabolic Disorders

Lesch-Nyhan Syndrome inherited, sex-linked recessive

massive excretion of urinary uric acid crystals

severe motor defects

mental retardation

tendency towards self-destruction, gout, and renal calculi

Page 47: Urine Screening for Metabolic Disorders

Diagnosis

normal development for the first 6-8 months

First Sign: uric acid crystals in diaper resembling orange sand

Increased uric acid crystals in pediatric urine specimen

Page 48: Urine Screening for Metabolic Disorders

Melituria

increased urinary sugar

usually caused by an inherited disorder

Most cause no disturbance in body metabolism

Type:

1. Pentosuria

2. Galactosuria

3. Lactosuria

4. Fructosuria

Page 49: Urine Screening for Metabolic Disorders

Pentosuria presence of pentose sugars in urine

one of Garrod’s original six IEMs

ingestion of large amounts of fruit

Page 50: Urine Screening for Metabolic Disorders

Galactosuria inability to properly metabolize galactose to

glucose

deficiency in any of the enzymes:

1. galactose-1-phosphate uridyl transferase (GALT) - causes severe, possible fatal symptoms

2. galactokinase - result in cataracts in adulthood

Page 51: Urine Screening for Metabolic Disorders

3. UDP-galactose-4-epimerase

asymptomatic or produce mild symptoms

results to galactosemia with toxic intermediate metabolic products

infant failure to thrive

liver disorder, cataracts, severe mental retardation

Page 52: Urine Screening for Metabolic Disorders

Lactosuria

may be seen during pregnancy and lactation

Page 53: Urine Screening for Metabolic Disorders

Fructosuria

associated with parenteral feeding

Page 54: Urine Screening for Metabolic Disorders

Diagnosis

Tests:

1. Copper reduction test – postive

2. Reagent strip glucose oxidase test – negative

3. Newborn screening tests

Page 55: Urine Screening for Metabolic Disorders

• Graff’s Textbook of Routine Urinalysis and Body Fluids by Mundt 2nd ed.• Concise Book of Medical Laboratory Technology: Methods and

Interpretations• William Clarke’s Contemporary Practice in Clinical Chemistry, 2nd ed.• Henry’s Clinical Diagnosis and Management by Laboratory Methods, 22nd

ed. by Mcpherson• Uniralysis and Other Body Fluids by Strasinger 6th ed.• Clinical Laboratory Medicine by Richard Ravel• Fundamentals of Urine and Body Fluids Analysis by Brunzel, 3rd ed.• Clinical Laboratory Science: the Basics and Routine Techniques, 6th ed. by

Turgeon• Inborn Metabolic Diseases: Diagnosis and Treatment by Saudubray 5th ed• Medical Biochemistry: Human Metabolism in Health and Disease by

Rosenthal• Clinical Chemistry: Principles, Techniques and Correlations by Bishop 7th

ed. 

References